Top 5 type 1 diabetes news articles of 2025
1. Nanoparticle therapy has potential to reprogram the immune system in type 1 diabetes COUR Pharmaceuticals is about to begin a phase 1b/2a study to assess a therapy for type…
1. Nanoparticle therapy has potential to reprogram the immune system in type 1 diabetes COUR Pharmaceuticals is about to begin a phase 1b/2a study to assess a therapy for type…